| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 01/24/2002 | US20020010204 Use as pesticides. |
| 01/24/2002 | US20020010189 For treatment of sexual disorders, male erectile dysfunction |
| 01/24/2002 | US20020010186 Dihydropyrimidines and uses thereof |
| 01/24/2002 | US20020010158 Derivatives of 5-pyridylalkylphosphonates and 5-pyridylalkylmalonates useful drugs for treatment of cardiovascular related diseases and diabetes mellitus related diseases |
| 01/24/2002 | US20020009905 Removable transceiver module and receptacle |
| 01/24/2002 | US20020009635 Novel materials for use as electrolytic solutes |
| 01/24/2002 | CA2416036A1 Substituted amidoalkyl-uracils as parp inhibitors |
| 01/24/2002 | CA2384041A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
| 01/23/2002 | EP1174431A2 2-Phenyl-substituited Imidazotriazinones as Phoshodiesterase Inhibitors |
| 01/23/2002 | EP1173520A1 Novel amidopyrylium fluorescence dyes |
| 01/23/2002 | EP1173454A1 Method for producing glyco-conjugates of 20(s)-camptothecin |
| 01/23/2002 | EP1173180A1 Camptothecin analogs and methods of preparation thereof |
| 01/23/2002 | EP0711292B1 Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity |
| 01/23/2002 | CN1332744A Tricyclic delta 3-piperidines as alpha 2-antagonists |
| 01/23/2002 | CN1332743A Cell adhesion-inhibiting antinflammatory compounds |
| 01/23/2002 | CN1332742A Epothilone derivatives and their use as antitumor agents |
| 01/23/2002 | CN1332174A Optical information gene material and its application in gene chip technology |
| 01/22/2002 | US6340761 Amination and dehydrohalogenation with piperidine compounds |
| 01/22/2002 | US6340759 Fused pyridine derivatives |
| 01/22/2002 | US6340755 5H-Pyrano[2,3-d: 6,5-d']dipyrimidine derivatives having an antibacterial, antiviral and immuno-modulating activity |
| 01/22/2002 | US6340745 Phthalocyanine and use of phthalocyanine as a marking agent |
| 01/22/2002 | US6340704 Cell differentiation inducing amide derivatives, their production and use |
| 01/22/2002 | US6340681 Useful as analgesics in mammals |
| 01/22/2002 | US6340680 Oxazinoquinolones useful for the treatment of viral infections |
| 01/17/2002 | WO2002004626A1 Fungal cell wall synthesis gene |
| 01/17/2002 | WO2002004460A1 Method for preparing (+)-biotine |
| 01/17/2002 | WO2002004457A1 Azepino[4,5-b]pyrano[3,2-e]indoles |
| 01/17/2002 | WO2002004456A1 SUBSTITUTED 2,3,7,8,9,10,11,12-OCTAHYDROAZEPINO[4,5-b]PYRANO[3,2-e]INDOLES |
| 01/17/2002 | WO2002004455A2 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 01/17/2002 | WO2002004443A2 Heterocycle carboxamides as antiviral agents |
| 01/17/2002 | WO2002004422A2 Heterocycle carboxamides as antiviral agents |
| 01/17/2002 | WO2001039759A3 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 01/17/2002 | WO2001030753A3 Enhancement of production of camptothecins from plants |
| 01/17/2002 | US20020007085 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 01/17/2002 | US20020007059 Potassium channel modulators relax smooth muscle cells and inhibit bladder contractions; treating nervous, eating, cardiovascular, gastrointestinal, and sexual disorders |
| 01/17/2002 | US20020006960 Neuraminidase inhibitors |
| 01/17/2002 | DE10033337A1 Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel Biphenylcarbonsäureamide, their preparation and their use as medicaments |
| 01/17/2002 | DE10033284A1 Verfahren zur Herstellung von (+)-Biotin A process for the preparation of (+) - Biotin |
| 01/17/2002 | DE10005302A1 Substituierte 1,2,3,4-Tetrahydrochinolin-2-carbonsäurederivate Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 01/17/2002 | CA2415569A1 Fungal cell wall synthesis gene |
| 01/16/2002 | CN1331692A Benzisozazoles and phenones as alpha antagonist |
| 01/16/2002 | CN1331076A Condensed pyrazole compound, composition containing it and its application |
| 01/15/2002 | US6339092 Metalloprotease inhibitors |
| 01/15/2002 | US6339091 Useful in therapy of of viral infections, parasitic diseases and cancer |
| 01/15/2002 | US6339085 For therapy of hypertrophy, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, heart failure subsequent to myocardial infarction, myocardial infarction, ischemia reperfusion injury, blood coagulation |
| 01/10/2002 | WO2002002744A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 01/10/2002 | WO2002002565A2 Glucocortiocoid-selective antiinflammatory agents |
| 01/10/2002 | WO2002002551A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 01/10/2002 | WO2001043697A3 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors |
| 01/10/2002 | WO2001000615A8 Respiratory syncytial virus replication inhibitors |
| 01/10/2002 | US20020004518 Pyrazolyl compound; anticoagulants, antiproliferative agent |
| 01/10/2002 | CA2415037A1 Glucocortiocoid-selective antiinflammatory agents |
| 01/10/2002 | CA2414468A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 01/09/2002 | EP1169322A1 Pyridoxal analogues for vitamin b-6 disorders |
| 01/09/2002 | EP1169038A1 Cyclic protein tyrosine kinase inhibitors |
| 01/09/2002 | EP0639190B1 Pyridine sulfonyl urea derivatives |
| 01/09/2002 | EP0607439B1 Nitrogenous heterocyclic compound |
| 01/09/2002 | CN1330650A Dibenz [a.g] quinolizinium derivatives and salts thereof |
| 01/09/2002 | CN1077575C Camptothecin derivatives and their manufacturing method and its intermediate |
| 01/08/2002 | US6337400 Process for the preparation of tetrahydroindolizines |
| 01/03/2002 | WO2002000657A2 Condensed pyrazindione derivatives |
| 01/03/2002 | WO2002000653A2 Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 01/03/2002 | WO2002000632A1 Benzodiazepines as inhibitors of hpv e1 helicase |
| 01/03/2002 | WO2002000631A2 Benzhydryl derivatives |
| 01/03/2002 | WO2002000617A2 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/03/2002 | WO2001066544A3 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 01/03/2002 | WO2000061146A9 Camptothecin analogs and methods of preparation thereof |
| 01/03/2002 | US20020002165 Growth hormone secretagogues useful for treatment/prevention of osteoporosis |
| 01/03/2002 | CA2413683A1 Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 01/03/2002 | CA2413596A1 Cell lines and cell-based assays for identification of androgen receptor modulators |
| 01/03/2002 | CA2413417A1 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/03/2002 | CA2411157A1 Benzodiazepines as inhibitors of hpv e1 helicase |
| 01/02/2002 | EP1166785A1 Use of pyrazole derivatives for inhibiting thrombin-induced platelet aggregation |
| 01/02/2002 | EP1165694A1 4,7-dichlororhodamine dyes useful as molecular probes |
| 01/02/2002 | EP1165565A1 Optically pure camptothecin analogues |
| 01/02/2002 | EP1165540A1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 01/02/2002 | EP1165511A2 Method of producing heterocyclic carbamates from aza-heterocyclic compounds and carbon dioxide |
| 01/02/2002 | EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 01/02/2002 | EP1165067A1 A process for the preparation of aziridinyl epothilones from oxiranyl epothilones |
| 01/02/2002 | EP0871630B1 4a,5a,8a,8b-TETRAHYDRO-6H-PYRROLO 3,4':4,5]FURO(3,2-b)PYRIDINE-6,8 7H]-DIONE DERIVATIVES FOR USE IN CONTROLLING ENDOPARASITES AND A METHOD OF PRODUCING SAID DERIVATIVES |
| 01/02/2002 | EP0835256B1 Microbicidal benzotriazoles |
| 01/02/2002 | EP0785938B1 Fused pyrrolocarbazoles |
| 01/02/2002 | CN1329607A Substituted benzopyran analogs for treatment of inflammation |
| 01/02/2002 | CN1077109C S type 2-substituted hydroxy 2-indolidinylbutyric ester compounds and process for preparation thereof |
| 01/01/2002 | US6335448 Method for the synthesis of quinoline derivatives |
| 01/01/2002 | US6335360 Indoline-2-carboxylic amide derivatives; obesity, eating and psychological disorders |
| 01/01/2002 | US6335358 Lactacystin analogs |
| 01/01/2002 | US6335345 Spiro compounds |
| 01/01/2002 | US6335344 Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases |
| 01/01/2002 | US6335328 Process for the isolation of galanthamine |
| 01/01/2002 | CA1341330C Substituted acyl dertivatives of 1,2,3,4-tetrahydroisquinoline-3-carboxylic acids |
| 12/27/2001 | WO2001098306A1 Compounds for treating impaired fundic relaxation |
| 12/27/2001 | US20010056113 Methods for the inhibition of angiogenesis with 6-amino EM-12 |
| 12/27/2001 | US20010056081 Treatment of cerebrovascular disease |
| 12/26/2001 | CN1328451A Drugs for improving vesical excretory strength |
| 12/25/2001 | US6333339 3-Benzylpiperidine |
| 12/25/2001 | US6333319 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 12/20/2001 | WO2001096347A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD |
| 12/20/2001 | WO2001095911A1 Protease inhibitors |
| 12/20/2001 | WO2001095856A2 Urea derivative useful as an anti-cancer agent and process for preparing same |